UK Launches First Human Trial for Nipah Virus Vaccine
Scientists at the University of Oxford in the UK have launched the first-in-human clinical trial to test a vaccine to protect people against deadly Nipah virus.
Stay updated with breaking news from Brian Angus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists at the University of Oxford in the UK have launched the first-in-human clinical trial to test a vaccine to protect people against deadly Nipah virus.
Scientists at the University of Oxford in the UK have launched the first-in-human clinical trial to test a vaccine to protect people against deadly Nipah virus.Fifty-one people aged 18 to 55 will participate in the trial of the ChAdOx1 NipahB ...
Scientists at the University of Oxford in the UK have launched the first-in-human clinical trial to test a vaccine to protect people against deadly Nipah virus.
The University of Oxford has begun the first human clinical trials of the ChAdOx1 NipahB vaccine, designed to combat the dangerous Nipah virus. Developed by
The trials of the ChAdOx1 NipahB vaccine, will consist of 51 people aged 18 to 55, which will be led by the Oxford Vaccine Group.